{"id":1160,"date":"2024-03-11T18:17:01","date_gmt":"2024-03-11T18:17:01","guid":{"rendered":"https:\/\/newsletters.aans.org\/tumor\/?page_id=1160"},"modified":"2024-03-28T19:38:13","modified_gmt":"2024-03-28T19:38:13","slug":"chairs-message","status":"publish","type":"page","link":"https:\/\/newsletters.aans.org\/tumor\/spring-2024\/chairs-message\/","title":{"rendered":"Chair’s Message"},"content":{"rendered":"

Isabelle M. Germano, MD, MBA<\/strong> \"\"
\nAANS\/CNS Section on Tumors Chair<\/strong><\/p>\n

 <\/p>\n

Dear Section on Tumors Members and Colleagues,<\/p>\n

The section\u2019s journey over the past six months, along with the anticipated event at the upcoming 2024 AANS Annual Scientific Meeting, has been truly extraordinary. I extend my heartfelt thanks<\/strong> to each of you<\/strong> for your active participation, enthusiasm and dedication to advancing our shared goal of prioritizing the needs of our brain and spine tumor patients. Additionally, I express deep appreciation to our industry and philanthropy<\/strong> partners for their unwavering support.<\/p>\n

We look forward to celebrating with you at the AANS\/CNS Section on Tumors 40th Anniversary<\/strong> at the meeting. Since its establishment in the spring of 1984 led by Dr. Mark Rosenblum<\/strong>, 17 successive chairpersons have assumed leadership, supported by and in collaboration with an expanding team of executive committee members and advisors. Find additional details at:\u00a0https:\/\/www.tumorsection.org\/media\/files\/pages-page\/87784cc2\/tumor-brochure-individual-pages.pdf<\/a><\/p>\n

Collaboratively with its members, the Section Chairpersons and their teams have brought the Section on Tumors to an unmatched level of prominence within its sphere, nationally and globally. Most importantly, they advanced the care of patients with brain and spine tumors. Please join us to celebrate this milestone during the Tumor Scientific Session on Sunday May 5, 2024, ending with the lecture \u201cAdvancing the Care of Brain and Spine Tumor Patients Over 40 Years\u201d by our section\u2019s historian, Ian Parney. In the evening, we will then gather to recognize the section\u2019s hard and successful work and celebrate those who paved the way.<\/p>\n

More details about the section\u2019s history were recently summarized in the Journal of Neurosurgery<\/em>, in the paper entitled: \u201cThe AANS\/CNS Section on Tumors: A Summary of 40 Years of Advocacy to Advance the Care of Patients with Brain and Spine Tumors,\u201d at: https:\/\/pubmed.ncbi.nlm.nih.gov\/38277647\/<\/a><\/p>\n

Additionally, the 2024 AANS Annual Meeting\u2019s Section on Tumors Scientific program, meticulously crafted by Kristin Huntoon<\/strong>, chair, Christine Lee<\/strong> and Ian Parney<\/strong>, co-chairs, alongside Analiz Rodriguez<\/strong>, AANS SPC Section on Tumors liaison, will also provide an engaging experience. Modular segments will delve into critical aspects of glioma, meningioma, craniopharyngioma and brain and spine metastasis surgery, inviting active audience participation. These sessions will be complemented by top-scoring scientific abstracts, with 14 distinguished individuals receiving Section on Tumors awards. We are thrilled to present the 2024 Bittner Endowed Lecture<\/strong> by Michael Lim<\/strong>, enhancing the program’s quality. Join us in congratulating the deserving awardees and expressing gratitude to Jennifer Moliterno<\/strong> and Frank Attenello<\/strong> for their leadership with the Award Subcommittee.<\/p>\n

Two other exciting additions of the section\u2019s special celebration at the 2024 AANS Annual Meeting include the inaugural AANS\/CNS Section on Tumors-EANS combined tumor board<\/strong> and an interactive scientific program. The former features case presentations by early career neurosurgeons (ECNS) and discussion by brain tumor experts from both continents. Crafted in collaboration with the Global Subcommittee, cochaired by Kate Drummond <\/strong>and Ekk Kasper<\/strong>, and the ECNS Subcommittee, led by Stephanie Cheok <\/strong>and Christian Bowers<\/strong>, this promises to be a dynamic exchange of insights and expertise.<\/p>\n

These exciting upcoming events follow a spectacular fall. What a splash! The 2023<\/strong> Biennial Section on Tumor Symposium<\/strong> held in Washington, DC, on September 8-9, 2023, marked several significant milestones. These included a record-breaking number of submitted abstracts<\/strong>, the highest number of industry and philanthropic partners<\/strong> and the successful launch of the inaugural neurosurgical oncology advanced practice provider (APP) course<\/strong>. Congratulations and thank you to the 2023 meeting chair Gelareh Zadeh<\/strong>, co-chairs Chetan Bettegowda<\/strong> and Pablo Recinos<\/strong> and our esteemed key keynote speakers Evanthia Galanis<\/strong> and David Louis<\/strong>. The section acknowledges Clinical Neurosurgery<\/em> for publishing the abstracts of the 37 accepted oral presentations and the Congress of Neurological Surgeons (CNS) staff for their support and dedication.<\/p>\n

The Section on Tumor\u2019s Special Awards<\/em><\/strong>, bestowed during the symposium section\u2019s chair Isabelle Germano, honored exemplary neurosurgery oncologists for their outstanding contributions. Please join me to congratulate Roberta Glick<\/strong>, for the Mark Rosenblum Distinguished Service Award, Linda Liau<\/strong>, for the Mark Rosenblum Distinguished Service Award, Nino Chiocca<\/strong>, for the Andrew T. Parsa Mentorship Award and Kate Drummond<\/strong>, for the inaugural Global Neurosurgery Oncology Award.<\/p>\n

The path planned for the section during my tenure has continued along the planned trajectory to corroborate the goals we had set. The Standard Operating Procedures<\/strong> (SOPs) finalized over the summer were unanimously approved by the Executive Committee at the CNS 2023 and are posted at: https:\/\/www.tumorsection.org\/bylaws\/<\/a>. The SOPs delineate the mission and objectives of each of the section’s 20 Executive Committee Subcommittees, ensuring clarity and alignment in operational functions. Additional goals and corresponding deliverables include:<\/p>\n